公司

Nexentis Technologies Inc.

关注打开结构图就此提问研究这家公司

Nexentis Technologies Inc. 的结构

Nexentis Technologies Inc.

公司

1 个关联

归属投资与持股1 / 2

关系出现时间2026待整理节点

Nexentis Technologies Inc.公司 · 1 个关联

第 1 层

归属投资与持股1

关系

箭头表示关系方向，可按业务类别筛选。

Nexentis Technologies Inc.拥有 →MitoCareX Bio
公司 · MitoCareX Bio证据 2
事实90%
查看证据
- 公司披露GlobeNewswire public company news2026-10-07 19:32
  Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
  查看来源
- 公司披露GlobeNewswire public company news2026-10-07 19:32
  MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
  查看来源
Nexentis Technologies Inc.投资 →solar projects
设施 · solar projects证据 1
事实90%
查看证据
- 公司披露GlobeNewswire public company news2026-10-07 19:32
  The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
  查看来源

显示第 1 至 2 条，共 2 条

结论

结合来源阅读结论，展开条目查看证据。

事实证据 1

投资solar projects

The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.

GlobeNewswire public company news · 2026-10-07 19:32

查看证据

公司披露GlobeNewswire public company news2026-10-07 19:32
The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
查看来源

事实证据 1

number of solar projects in which it is the lead investorfour

GlobeNewswire public company news · 2026-10-07 19:32

查看证据

公司披露GlobeNewswire public company news2026-10-07 19:32
The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
查看来源

事实证据 2

拥有MitoCareX Bio

Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.

GlobeNewswire public company news · 2026-10-07 19:32

查看证据

公司披露GlobeNewswire public company news2026-10-07 19:32
Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
查看来源
公司披露GlobeNewswire public company news2026-10-07 19:32
MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
查看来源

显示第 1 至 3 条，共 3 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

暂无: 公司信号 · 财务数据 · 披露文件 · 业绩指引